United States · FDA National Drug Code directory
Metformin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-652_2f692050-7ea1-49b8-a19d-3b0134b7aa2a
- Product NDC
- 71610-652
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Metformin Hydrochloride
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220328
- Source listing expiry
- 20261231
Source-listed ingredients
- METFORMIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-652-30) · 71610-652-30
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-652-53) · 71610-652-53
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-652-60) · 71610-652-60
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-652-70) · 71610-652-70
- 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-652-80) · 71610-652-80
- 360 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-652-94) · 71610-652-94
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →